CHK1 is also overexpressed in many patient samples (average Z-score = 4.71, Figure 1B) and is known to promote tumor growth and confer resistance to chemotherapy, indicating that it may be playing a role in EWS tumor progression and survival [43,44,45]. This evidence concerns the gene CHEK1 and neoplasm.